Opiant Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
OPNT Opiant Pharmaceuticals Inc
ADAG Adagene Inc
TSLA Tesla Inc
APCX AppTech Payments Corp
CURV Torrid Holdings Inc
MMSBF Megmilk Snow Brand Co Ltd
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund
CEFC Commercial National Financial Corp (Michigan)
CNVCF Bioharvest Sciences Inc
GECC Great Elm Capital Corp
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Opiant Pharmaceuticals, Inc., is a specialty pharmaceutical company developing medicines for addictions and drug overdose. The Company has developed NARCAN (naloxone hydrochloride) Nasal Spray, a treatment to reverse opioid overdose. Its lead development product include OPNT003. The Company’s pipeline includes medicines in development for Opioid Overdose Reversal (OOR), Alcohol Use Disorder (AUD), Opioid Use Disorder (OUD), and Acute Cannabinoid Overdose (ACO). The Company also is focused on other treatment opportunities within the addiction and drug overdose field.

Closing Price
$20.20
Day's Change
0.10 (0.50%)
Bid
--
Ask
--
B/A Size
--
Day's High
20.25
Day's Low
20.02
Volume
(Light)
Volume:
22,855

10-day average volume:
87,975
22,855
  • Prev Close
    20.10
  • Today's Open
    20.02
  • Day's Range
    20.02-20.25
  • Avg Vol (10-day)
    88.0K
  • Last (time)
    4:00p ET 02/03/23
  • Last (size)
    16
  • 52-Wk Range
    7.34 - 32.27
    LowHigh
  • (02/16/22 - 05/13/22)
    37.40%
  • 108.7%
  • Market Cap
    106.4M
  • Shares Outstanding
    5.3M
  • -6.56
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.9
  • 38.53
  • (% of float 01/15/23)
    0.58

Latest News

January 19, 2023
4:05 pm ET
Globe Newswire
January 08, 2023
8:47 am ET
Globe Newswire
December 14, 2022
9:23 am ET
Globe Newswire
December 13, 2022
6:14 pm ET
PR Newswire
December 11, 2022
11:45 am ET
Accesswire
December 10, 2022
8:07 pm ET
Globe Newswire
December 08, 2022
12:00 am ET
Globe Newswire
December 07, 2022
3:34 pm ET
PR Newswire
December 06, 2022
12:07 pm ET
PR Newswire
December 05, 2022
12:21 pm ET
Globe Newswire
December 01, 2022
11:35 am ET
PR Newswire
November 30, 2022
10:15 pm ET
PR Newswire
7:46 pm ET
Globe Newswire
November 27, 2022
10:26 am ET
Globe Newswire
November 25, 2022
4:03 pm ET
PR Newswire
November 24, 2022
7:31 am ET
Accesswire
November 23, 2022
7:48 pm ET
Accesswire
November 22, 2022
4:01 pm ET
Globe Newswire
11:10 am ET
PR Newswire
November 21, 2022
10:04 am ET
Newsfile
November 20, 2022
10:59 am ET
Globe Newswire
November 19, 2022
8:07 pm ET
Globe Newswire
November 18, 2022
3:38 pm ET
PR Newswire
November 15, 2022
8:17 am ET
Globe Newswire
November 14, 2022
10:25 pm ET
PR Newswire
4:43 pm ET
PR Newswire
1:17 pm ET
Globe Newswire
12:30 pm ET
PR Newswire
10:37 am ET
PR Newswire
10:27 am ET
BusinessWire
10:25 am ET
PR Newswire
9:27 am ET
Newsfile
8:35 am ET
MarketWatch
2:13 am ET
Globe Newswire
2:12 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.